• Home
  • Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer.

Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer.

Author List
Murphy AG, Foley K, Rucki AA, Xia T, Jaffee EM, Huang CY, Zheng L
Publication
Oncotarget
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1216235
Publication Year
2017
PubMed ID
29290958
Publication Title
Murphy AG, Foley K, Rucki AA, Xia T, Jaffee EM, Huang CY, Zheng L. Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. Oncotarget. 2017 Dec 05; 8(63):106405-106414.